{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:35:10Z","timestamp":1788870910212,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["271-07-0582"],"award-info":[{"award-number":["271-07-0582"]}],"id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008445","name":"Parkinsonforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008733","name":"H\u00f8rslev-Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000782","name":"European Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["3100A0-112529"],"award-info":[{"award-number":["3100A0-112529"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004965","name":"Sixth Framework Programme","doi-asserted-by":"publisher","award":["ERAS-CT-2003-980409"],"award-info":[{"award-number":["ERAS-CT-2003-980409"]}],"id":[{"id":"10.13039\/501100004965","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.yexcr.2011.04.012","type":"journal-article","created":{"date-parts":[[2011,5,4]],"date-time":"2011-05-04T12:38:36Z","timestamp":1304512716000},"page":"1649-1662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Enhanced proliferation and dopaminergic differentiation of ventral mesencephalic precursor cells by synergistic effect of FGF2 and reduced oxygen tension"],"prefix":"10.1016","volume":"317","author":[{"given":"Pia","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Bert","family":"Gramsbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans R.","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2011.04.012_bb0005","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0079-6123(08)62664-3","article-title":"Therapeutic effects of human fetal dopamine cells transplanted in a patient with Parkinson's disease","volume":"82","author":"Freed","year":"1990","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0010","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0166-2236(96)80038-5","article-title":"Fetal nigral transplantation as a therapy for Parkinson's disease","volume":"19","author":"Olanow","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/16060","article-title":"Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient","volume":"2","author":"Piccini","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1602\/neurorx.1.4.382","article-title":"Cell therapy in Parkinson's disease","volume":"1","author":"Lindvall","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.yexcr.2011.04.012_bb0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.trim.2003.12.012","article-title":"The cellular repair of the brain in Parkinson's disease\u2014past, present and future","volume":"12","author":"Sayles","year":"2004","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tins.2004.12.006","article-title":"Cell transplantation in Parkinson's disease: how can we make it work?","volume":"28","author":"Winkler","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneumeth.2007.05.019","article-title":"Neural tissue-spheres: a microexplant culture method for propagation of precursor cells from the rat forebrain subventricular zone","volume":"165","author":"Andersen","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.yexcr.2011.04.012_bb0045","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1523\/JNEUROSCI.19-11-04484.1999","article-title":"Generation of tyrosine hydroxylase-producing neurons from precursors of the embryonic and adult forebrain","volume":"19","author":"Daadi","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0050","doi-asserted-by":"crossref","first-page":"11879","DOI":"10.1073\/pnas.92.25.11879","article-title":"Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain","volume":"92","author":"Gage","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0055","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.1553558","article-title":"Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system","volume":"255","author":"Reynolds","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2011.04.012_bb0060","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0361-9230(01)00772-9","article-title":"Stem cells in the treatment of Parkinson's disease","volume":"57","author":"Arenas","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-7091-0641-9_1","article-title":"Recent advances in stem cell neurobiology","volume":"28","author":"Ostenfeld","year":"2003","journal-title":"Adv. Tech. Stand. Neurosurg."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00441-004-0946-y","article-title":"Stem cell therapy for Parkinson's disease: where do we stand?","volume":"318","author":"Roybon","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0075","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/01.wco.0000174298.27765.91","article-title":"Stem cell treatment for Parkinson's disease: an update for 2005","volume":"18","author":"Snyder","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/1105","article-title":"Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats","volume":"1","author":"Studer","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/japplphysiol.00831.2003","article-title":"Oxygen-sensing neurons in the central nervous system","volume":"96","author":"Neubauer","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0034-5687(01)00306-1","article-title":"Tissue oxygen tension and brain sensitivity to hypoxia","volume":"128","author":"Erecinska","year":"2001","journal-title":"Respir. Physiol."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0095","doi-asserted-by":"crossref","first-page":"7377","DOI":"10.1523\/JNEUROSCI.20-19-07377.2000","article-title":"Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen","volume":"20","author":"Studer","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0100","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1471-4159.2004.02893.x","article-title":"Low atmospheric oxygen avoids maturation, senescence and cell death of murine mesencephalic neural precursors","volume":"92","author":"Milosevic","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/exnr.2001.7706","article-title":"Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells","volume":"170","author":"Storch","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0110","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.expneurol.2008.06.014","article-title":"Combined use of BDNF, ascorbic acid, low oxygen, and prolonged differentiation time generates tyrosine hydroxylase-expressing neurons after long-term in vitro expansion of human fetal midbrain precursor cells","volume":"213","author":"Maciaczyk","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0115","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/j.1471-4159.2009.06281.x","article-title":"Enhanced dopaminergic differentiation of human neural stem cells by synergistic effect of Bcl-xL and reduced oxygen tension","volume":"110","author":"Krabbe","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0120","doi-asserted-by":"crossref","first-page":"10786","DOI":"10.1523\/JNEUROSCI.3208-04.2004","article-title":"The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo","volume":"24","author":"Liste","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0125","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/jnr.21327","article-title":"Expansion and characterization of ventral mesencephalic precursor cells: effect of mitogens and investigation of FA1 as a potential dopaminergic marker","volume":"85","author":"Jensen","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2008.04.039","article-title":"Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease","volume":"1218","author":"Jensen","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/exnr.2000.7419","article-title":"Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line","volume":"164","author":"Meyer","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0006-8993(02)02451-4","article-title":"Glutathione depletion in nigrostriatal slice cultures: GABA loss, dopamine resistance and protection by the tetrahydrobiopterin precursor sepiapterin","volume":"935","author":"Gramsbergen","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuint.2007.08.008","article-title":"Nitration of soluble proteins in organotypic culture models of Parkinson's disease","volume":"52","author":"Larsen","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0306-4522(01)00418-3","article-title":"Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4\/5 on rat fetal nigral explant cultures","volume":"108","author":"Meyer","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.yexcr.2011.04.012_bb0155","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0021-9258(19)76979-8","article-title":"Solubilization and partial purification of tyrosine hydroxylase from bovine adrenal medulla","volume":"246","author":"Shinan","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0160","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1111\/j.1460-9568.2005.04138.x","article-title":"Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF","volume":"21","author":"Jakobsen","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.yexcr.2011.04.012_bb0165","first-page":"39","article-title":"Gene therapy for Parkinson's disease: determining the genes necessary for optimal dopamine replacement in rat models","volume":"14","author":"Kang","year":"2001","journal-title":"Hum. Cell"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482711001492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482711001492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:11:07Z","timestamp":1762146667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482711001492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0014482711001492"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2011.04.012","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced proliferation and dopaminergic differentiation of ventral mesencephalic precursor cells by synergistic effect of FGF2 and reduced oxygen tension","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2011.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}